Canaccord Genuity Reiterates a 'Buy' on Vascular Solutions (VASC); Margin Leverage Near a Tipping Point
Tweet Send to a Friend
Canaccord Genuity reiterates a 'Buy' on Vascular Solutions (NASDAQ: VASC), raises PT to $15.50.
Canaccord analyst says, "Q4 results were ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "Q4 results were ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
